Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
13F holders, Q2 2025
Institutional positions in Iterum Therapeutics plc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +4 vs. Q1 2025
- Shares held
- 2.39M
- +1.27M (+113.5%) vs. Q1 2025
- Total value
- $2.38M
- +$1.00M (+72.7%) vs. Q1 2025
- New holders
- 6
- 5 more added
- Sold out
- 2
- 1 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $542 |
| Q1 2026 | 18 | $41.3K |
| Q4 2025 | 20 | $557.9K |
| Q3 2025 | 24 | $904.1K |
| Q2 2025 | 24 | $2.38M |
| Q1 2025 | 20 | $1.38M |
| Q4 2024 | 24 | $2.18M |
| Q3 2024 | 18 | $2.22M |
| Q2 2024 | 15 | $494.7K |
| Q1 2024 | 18 | $1.43M |
| Q4 2023 | 16 | $761.6K |
| Q3 2023 | 15 | $184.0K |
| Q2 2023 | 17 | $393.4K |
| Q1 2023 | 17 | $187.3K |
| Q4 2022 | 23 | $243.7K |
| Q3 2022 | 25 | $575.4K |
| Q2 2022 | 39 | $1.18M |
| Q1 2022 | 41 | $1.80M |
| Q4 2021 | 45 | $2.57M |
| Q3 2021 | 42 | $3.45M |
| Q2 2021 | 45 | $26.0M |
| Q1 2021 | 50 | $11.2M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Iterum Therapeutics plc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 5 | $0 | 0.00% | +5 | New |
| HM Payson & Co | 3 | $3 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 15 | $15 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 16 | $16 | 0.00% | −2−11.1% | Reduced |
| Blue Bell Private Wealth Management, LLC | 66 | $66 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 85 | $85 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 133 | $132 | 0.00% | 00.0% | Unchanged |
| Medallion Wealth Advisors, LLC | 1,680 | $1.67K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 4,513 | $4.49K | 0.00% | +4,513 | New |
| UBS Group AG | 8,799 | $8.76K | 0.00% | +100+1.1% | Added |
| Morgan Stanley | 9,373 | $9.33K | 0.00% | +2,900+44.8% | Added |
| Alpine Global Management, LLC | 10,000 | $9.95K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 11,500 | $11.4K | 0.00% | +11,500 | New |
| Geode Capital Management, LLC | 12,370 | $12.3K | 0.00% | 00.0% | Unchanged |
| Sanctuary Advisors, LLC | 20,000 | $19.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 25,245 | $25.1K | 0.00% | 00.0% | Unchanged |
| Creative Financial Designs Inc | 76,047 | $75.7K | 0.01% | +6,100+8.7% | Added |
| Jane Street Group, LLC | 92,943 | $92.5K | 0.00% | +92,943 | New |
| Resources Investment Advisors, LLC. | 161,000 | $160.2K | 0.00% | +60,000+59.4% | Added |
| Apollon Financial, LLC | 250,250 | $249.0K | 0.05% | 00.0% | Unchanged |
| New Leaf Venture Partners, L.L.C. | 345,020 | $343.3K | 1.04% | 00.0% | Unchanged |
| Sabby Management, LLC | 430,761 | $428.6K | 3.30% | +430,761 | New |
| Squarepoint Ops LLC | 456,861 | $454.6K | 0.00% | +456,861 | New |
| Renaissance Technologies LLC | 471,900 | $469.5K | 0.00% | +231,000+95.9% | Added |
| Lee Financial Co | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,709−100.0% | Sold out |